Research suggests it may modulate the expression of genes involved in tissue remodeling, support collagen and elastin synthesis, and activate antioxidant and anti-inflammatory pathways
The FDA also noted emideltide is poorly understood and that well-tested, approved treatments already exist for both conditions
This is the first step toward developing that knowledge, which will require large-scale, carefully controlled clinical trials." Rasgon is a member of the Stanford Neurosciences Institute
Effectiveness and Side Effects: Tirzepatide is a dual receptor agonist, which is why it is a potentially more potent treatment, but its use may also be associated with more side effects compared to liraglutide
The palmitoyl group enables the peptide to penetrate much further into the skin compared to the unmodified peptide, allowing these benefits to reach the deeper layers of the skin